Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Marksans Pharma Ltd. Major Shareholding Notification 2021

Apr 9, 2021

62142_rns_2021-04-09_3a8331de-b78f-428b-8cd2-b28689bfdb24.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Date: 5th April, 2021

BSE Limited Corporate Relation Department Phiroze Jeejeeboi Towers, Dalal Street. Mumbai - 400001. Scrip Code: 524404

National Stock Exchange of India Limited Listing Department Exchange Plaza, C-1, Block-G, Bandra-Kurla Complex, Bandra (E), Mumbai - 400051. Symbol: MARKSANS

Sub: Disclosure under Regulation 30(2) and 31(4) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011

Dear Sir,

We, the undersigned as promoters of Marksans Pharma Limited, hereby enclose disclosure of our shareholding in Marksans Pharma Limited as on 31st March, 2021 pursuant to the Regulation 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

We also enclose disclosure regarding encumbrance of shares under Regulation 31(4) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Thanking you.

Yours faithfully,

Mark Saldanha Enelosed as above

Sandra Saldanha

CC.: Marksans Pharma Limited 11th Floor, Grandeur, Off Veera Desai Extension Road. Oshiwara, Andheri (West), Mumbai - 400053.

Disclosures under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011

Part A: Details of Shareholding

1. Name of the Target Company (TC) MARKSANS PHARMA LIMITED
Name(s) of the Stock Exchange(s) where the2.shares of the TC are listed 1. The National Stock Exchange Limited2. BSE Limited
3. Particulars of the shareholdera. Name of person whose total holding (includingthat in the form of shares, warrants, convertiblesecurities and any other instrument that wouldentitle the holder to receive shares in the targetcompany) is more than 25% of the share orvoting rights of the TC.or Not Applicable
Name(s) of promoter(s), member of theb.promoter group and Persons Acting in Concert(PAC) with him. 1.Mr. Mark Saldanha2. Mrs. Sandra Saldanha
Particulars of the holding of persons mentioned at4.$(3)$ above Number % w.r.t. totalshare/votingcapitalwhereverapplicable of$\frac{a}{2}$totaldilutedshare/votingcapital of TC (*)
As on March 31 st of the year 2021, holding of:a) Shares
1. Mr. Mark Saldanha 197491553 48.25 48.24
2.Mrs. Sandra Saldanha 180 0.00 0.00
Voting Right (otherwise than by shares)b)
Warrants$c$ )
d) Convertible Securities
e) Any other instruments that would entitle theholder to receive shares in the TC
TOTAL 197491733 48.25 48.24

(*) Diluted shares/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC. It includes 81314 equity shares that might be issued in case conversion right is exercised by all the holders of outstanding Foreign Currency Convertible Bonds of the TC.

Mark Saldanha

Sandra Saldanha

Place: Mumbai Date: 5th April, 2021

Part B

Name of the Target Company (TC): Marksans Pharma Limited

Names of the person and Whether the person belongto PAN ofthe person and PAC
Persons Acting Concert(PAC) promoter or promoter group
with the person
Mr. Mark Saldanha Yes
Mrs. Sandra Saldanha Yes

() \ . l &i�

Sandra Saldanha

Place: Mumbai Date: 5 th April, 2021

Date: 5th April, 2021

BSE Limited Corporate Relation Department Phiroze Jeejeeboi Towers, Dalal Street. Mumbai - 400001. Scrip Code: 524404

National Stock Exchange of India Limited Listing Department Exchange Plaza, C-1, Block-G, Bandra-Kurla Complex, Bandra (E), Mumbai - 400051. Symbol: MARKSANS

Sub: Disclosures under Regulation 31(4) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011

Dear Sir,

We, the undersigned as promoters of Marksans Pharma Limited, hereby declare under Regulation 31(4) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 that we have not made any encumbrance, directly or indirectly, of our shares held in Marksans Pharma Limited.

Thanking you.

Yours faithfully,

Mark Saldanha

Sandra Saldanha

CC.: Audit Committee of Directors Marksans Pharma Limited 11th Floor, Grandeur, Off Veera Desai Extension Road, Oshiwara, Andheri (West), Mumbai - 400053.